{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:31:17Z","timestamp":1772253077409,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"Commonwealth of Pennsylvania, Department of Community and Economic Development","doi-asserted-by":"publisher","award":["1R21AI158044-01"],"award-info":[{"award-number":["1R21AI158044-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Without sufficient herd immunity through either vaccination or natural infection, the coronavirus disease 2019 pandemic is unlikely to be controlled. Waning immunity with the currently approved vaccines suggests the need to evaluate vaccines causing the induction of long-term responses. Here, we report the immunogenicity and efficacy of our adjuvanted single-dose Rabies-vectored SARS-CoV-2 S1 vaccine, CORAVAX, in hamsters. CORAVAX induces high SARS-CoV-2 S1-specific and virus-neutralizing antibodies (VNAs) that prevent weight loss, viral loads, disease, lung inflammation, and the cytokine storm in hamsters. We also observed high Rabies VNA titers. In summary, CORAVAX is a promising dual-antigen vaccine candidate for clinical evaluation against SARS-CoV-2 and Rabies virus.<\/jats:p>","DOI":"10.3390\/v14061126","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T05:12:27Z","timestamp":1653455547000},"page":"1126","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model"],"prefix":"10.3390","volume":"14","author":[{"given":"Drishya","family":"Kurup","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-3572","authenticated-orcid":false,"given":"Leila","family":"Zabihi Diba","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Ramage","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Solomides","sequence":"additional","affiliation":[{"name":"Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA"},{"name":"Jefferson Vaccine Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"ref_1","unstructured":"Ritchie, H., Mathieu, E., Rod\u00e9s-Guirao, L., Appel, C., Giattino, C., Ortiz-Ospina, E., Hasell, J., Macdonald, B., Beltekian, D., and Dattani, S. (2021, December 02). Coronavirus Pandemic (COVID-19). Available online: https:\/\/ourworldindata.org\/coronavirus."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coviro.2021.04.008","article-title":"SARS-CoV-2 vaccines\u2014The biggest medical research project of the 21st century","volume":"49","author":"Kurup","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.15585\/mmwr.mm7049a2","article-title":"Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans\u2014Five Veterans Affairs Medical Centers, United States, 1 February\u201330 September 2021","volume":"70","author":"Bajema","year":"2021","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm7038e1","article-title":"Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations among Adults without Immunocompromising Conditions\u2014United States, March\u2013August 2021","volume":"70","author":"Self","year":"2021","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against COVID-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_7","unstructured":"CDC (2021, December 01). Johnson & Johnson\u2019s Janssen COVID-19 Vaccine: Overview and Safety, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/janssen.html."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2109744118","DOI":"10.1073\/pnas.2109744118","article-title":"A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters","volume":"118","author":"Liu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Cohn, B.A., Cirillo, P.M., Murphy, C.C., Krigbaum, N.Y., and Wallace, A.W. (2021). Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, 1 February 2021 to 13 August 2021. medRxiv.","DOI":"10.1101\/2021.10.13.21264966"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"103401","DOI":"10.1016\/j.ebiom.2021.103401","article-title":"SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors","volume":"68","author":"Frieman","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41541-020-00248-6","article-title":"Rabies virus-based COVID-19 vaccine CORAVAX\u2122 induces high levels of neutralizing antibodies against SARS-CoV-2","volume":"5","author":"Kurup","year":"2020","journal-title":"npj Vaccines"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/jiab014","article-title":"Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates","volume":"224","author":"Kurup","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kurup, D., Malherbe, D.C., Wirblich, C., Lambert, R., Ronk, A.J., Diba, L.Z., Bukreyev, A., and Schnell, M.J. (2021). Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model. PLoS Pathog., 17.","DOI":"10.1101\/2021.01.19.427373"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/infdis\/jiz332","article-title":"Inactivated Rabies Virus\u2013Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge","volume":"220","author":"Kurup","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101495","DOI":"10.1016\/j.trim.2021.101495","article-title":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses","volume":"70","author":"Molavi","year":"2022","journal-title":"Transpl. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"626553","DOI":"10.3389\/fmicb.2021.626553","article-title":"Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates","volume":"12","author":"Shou","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1473-3099(21)00676-9","article-title":"Protective immunity after recovery from SARS-CoV-2 infection","volume":"22","author":"Kojima","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2666-5247(21)00219-6","article-title":"The durability of immunity against reinfection by SARS-CoV-2: A comparative evolutionary study","volume":"2","author":"Townsend","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Goldberg, Y., Mandel, M., Bar-On, Y.M., Bodenheimer, O., Freedman, L., Ash, N., Alroy-Preis, S., Huppert, A., and Milo, M. (2021). Protection and waning of natural and hybrid COVID-19 immunity. medRxiv.","DOI":"10.1101\/2021.12.04.21267114"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S2213-2600(21)00458-6","article-title":"Waning immunity to SARS-CoV-2: Implications for vaccine booster strategies","volume":"9","author":"Altmann","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103586","DOI":"10.1016\/j.ebiom.2021.103586","article-title":"Vaccination after prior COVID-19 infection: Implications for dose sparing and booster shots","volume":"72","author":"Kent","year":"2021","journal-title":"eBioMedicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/d41586-021-02795-x","article-title":"COVID super-immunity: One of the pandemic\u2019s great puzzles","volume":"598","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) COVID-19 Vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eabl8213","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1093\/eurheartj\/ehab712","article-title":"Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination","volume":"42","author":"Crea","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3324\/haematol.2021.279729","article-title":"Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination","volume":"107","author":"Misasi","year":"2021","journal-title":"Haematologica"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1093\/eurheartj\/ehab592","article-title":"Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: The FAPIC score","volume":"42","author":"Hwang","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_28","first-page":"e2273","article-title":"Vaccine-induced immune thrombotic thrombocytopenia after vaccination against COVID-19: A clinical dilemma for clinicians and patients","volume":"32","author":"Babazadeh","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rzymski, P., Perek, B., and Flisiak, R. (2021). Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism. Vaccines, 9.","DOI":"10.3390\/vaccines9060559"},{"key":"ref_30","first-page":"646","article-title":"Case Report: Thrombotic Thrombocytopenia after COVID-19 Janssen Vaccination","volume":"103","author":"Costello","year":"2021","journal-title":"Am. Fam. Physician"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2213-2600(21)00409-4","article-title":"Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: An exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial","volume":"10","author":"Toback","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and Efficacy of NVX-CoV2373 COVID-19 Vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_33","unstructured":"(2021, December 21). The Novavax Vaccine against COVID-19: What You Need to Know. Available online: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-novavax-vaccine-against-covid-19-what-you-need-to-know."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: Review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"key":"ref_37","unstructured":"Centers for Disease Control and Prevention, and National Center for Emerging and Zoonotic Infectious Diseases (2022, February 07). Precautions or Contraindications for Rabies Vaccination, Available online: https:\/\/www.cdc.gov\/rabies\/specific_groups\/hcp\/vaccination_precautions.html."},{"key":"ref_38","unstructured":"(2021, August 16). A Phase 1, Open Label, Dose Escalation, Randomized, Multicenter Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of an Intramuscular Inactivated Rabies Vector Platform Corona Virus Vaccine (rDNA-BBV151) in Healthy Volunteers. Available online: http:\/\/ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=58694&EncHid=&userName=BBV151."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100121","DOI":"10.1016\/j.xcrm.2020.100121","article-title":"Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian\nHamsters","volume":"1","author":"Lee","year":"2020","journal-title":"Cell Rep. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1126\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:17:50Z","timestamp":1760138270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/6\/1126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["v14061126"],"URL":"https:\/\/doi.org\/10.3390\/v14061126","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.21.481324","asserted-by":"object"}]},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}